Arcus Biosciences, Inc.
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

Last updated:

Abstract:

Compounds that modulate the conversion of AMP to adenosine by 5'-nucleotidase, ecto, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by 5'-nucleotidase, ecto is also provided.

Status:
Application
Type:

Utility

Filling date:

19 Mar 2021

Issue date:

2 Dec 2021